PDL BioPharma (PDLI)
PDL BioPharma Key Statistics
Pro Data ExportCurrent Valuation
| Market Cap | 905.02M |
| Enterprise Value | 1.067B |
| PE Ratio | 5.437 |
| PE 10 Pro | Go Pro |
| PEG Ratio | 0.0633 |
| Price / Sales Ratio | 2.542 |
| Price / Book Value | |
| EV / Revenues Pro | Go Pro |
| EV / EBITDA Pro | Go Pro |
| EV / EBIT Pro | Go Pro |
| Operating Earnings Yield Pro | Go Pro |
Dividends and Shares
| Dividend | |
| Dividend Yield | 9.11% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | Sept. 14, 2012 |
| Ex-Dividend Date | Sept. 5, 2012 |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | 51.95% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 1.378 |
| Debt to Equity Ratio | |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | 2.86% |
| Year to Date Stock Returns | 4.35% |
| 1 Year Stock Returns | -2.56% |
| 3 Year Stock Returns | -6.91% |
| 52 Week High | 6.70 |
| 52 Week Low | 5.15 |
Income Statement
| Revenues TTM | 356.05M |
| Revenue Per Share TTM | 2.545 |
| Revenue Growth | -7.19% |
| Gross Profit TTM | 356.05M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | 195.03M |
| Earnings Per Share TTM | 1.19 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | 6.958M |
| Cash Financing TTM | -193.13M |
| Cash Operations TTM | 200.83M |
| Capital Expenditures | 0.008M |
Share Statistics
| Shares Outstanding | 139.88M |
Balance Sheet
| Cash and ST Investments | 187.38M |
| Total Assets | 234.96M |
| Liabilities | 478.74M |
| Book Value | -243.78M |
| Book Value per Share | -1.743 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 302.24M |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these PDLI related companies
PDLI News
Stocks trading ex-dividend one week from today: http://stks.co/40f2 $BLK $BEBE $BOX $CEC $LEA $LPS $PDLI $PX ...
about 3 days ago by DynamicDividend
about 3 days ago by DynamicDividend
$PDLI http://stks.co/408f top of expanding wedge, over 6.60 BO w/ 7.10 target initally
about 4 days ago by harmongreg
about 4 days ago by harmongreg
$PDLI http://stks.co/3wcN approaching breakout point on a volume spike... http://stks.co/3wcO
about 9 days ago by TraderHR
about 9 days ago by TraderHR
@Fibline Nice list yessir, liking $SLXP from last week, bought $ARIA today, like the divy on $PDLI, hope it breaks up
about 17 days ago by harmongreg
about 17 days ago by harmongreg
@Legacy_Trades you still like $PDLI here? TA looking up, but would appreciate your FA view.
about 21 days ago by gtlackey
about 21 days ago by gtlackey
Watchlist 5/7.Careful tday but following charts look ready for a small run.$KGJI,$AFFX,$GEOY,$NAVG,$PDLI,$VNET.Look for intraday weakness.
about 25 days ago by traderNC
about 25 days ago by traderNC
PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript
May 03, 6:52PM Seeking Alpha
May 03, 6:52PM Seeking Alpha
Listen to $PDLI Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3eza
about 28 days ago by earningscast
about 28 days ago by earningscast
PDL BioPharma to Announce First Quarter 2012 Financial Results on May 3, 2012
Apr 27, 5:56PM PR Newswire
Apr 27, 5:56PM PR Newswire
PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million
Mar 08, 4:02PM PR Newswire
Mar 08, 4:02PM PR Newswire
$PDLI forms bearish "Double Top" chart pattern. http://stks.co/2haG
about 86 days ago by RecogniaEvents
about 86 days ago by RecogniaEvents
PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes
Mar 05, 4:02PM PR Newswire
Mar 05, 4:02PM PR Newswire
7 High Profitable Healthcare Dividend Stocks With Fantastic Yields + http://stks.co/2dw4 + $PDLI $AZN $PMD $GSK $BMY $NVO $SHPGY
about 91 days ago by DividendYield
about 91 days ago by DividendYield
PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb 23, 10:46PM Seeking Alpha
Feb 23, 10:46PM Seeking Alpha
Listen to $PDLI Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2XOK
about 98 days ago by earningscast
about 98 days ago by earningscast
$PDLI Reports Q4 EPS $0.24 vs $0.24 Est; Revenues $72.8M vs $72.85M Est
about 98 days ago by Benzinga
about 98 days ago by Benzinga
PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
Feb 23, 4:00PM PR Newswire
Feb 23, 4:00PM PR Newswire
PDL BioPharma to Announce Fourth Quarter and Full Year 2011 Financial Results on February 23, 2012
Feb 16, 7:00AM PR Newswire
Feb 16, 7:00AM PR Newswire
Seth Klarman's Baupost Group drastically reduces PDL BioPharma $PDLI position http://stks.co/2LmR
about 111 days ago by marketfolly
about 111 days ago by marketfolly
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PDLI | 6.47 | -0.01 | -0.15% | 906.42M |
| PDII | 7.41 | -0.05 | -0.67% | 111.08M |
| PDFS | 8.84 | +0.10 | +1.14% | 248.74M |
| PDEX | 2.00 | +0.15 | +8.11% | 6.54M |
| ROG | 40.26 | +0.26 | +0.65% | 650.80M |
| RODM | 0.50 | -0.08 | -13.79% | 19.95M |
| ROCM | 9.95 | +0.00 | +0.00% | 120.40M |
| ROCK | 10.24 | +0.00 | +0.00% | 312.73M |
| ROC | 48.40 | -0.43 | -0.88% | 3.778B |
| RNWKD | 8.72 | -0.09 | -1.02% |